SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785982-21-000092
Filing Date
2021-05-17
Accepted
2021-05-17 13:35:06
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sf0114h_10q.htm 10-Q 464719
2 EXHIBIT 31-1 sf0114h_ex31-1.htm EX-31.1 10881
3 EXHIBIT 32-1 sf0114h_ex32-1.htm EX-32.1 5601
  Complete submission text file 0001785982-21-000092.txt   4370964

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bixt-20210331.xml EX-101.INS 869433
5 XBRL SCHEMA FILE bixt-20210331.xsd EX-101.SCH 51802
6 XBRL CALCULATION FILE bixt-20210331_cal.xml EX-101.CAL 44019
7 XBRL DEFINITION FILE bixt-20210331_def.xml EX-101.DEF 242387
8 XBRL LABEL FILE bixt-20210331_lab.xml EX-101.LAB 396396
9 XBRL PRESENTATION FILE bixt-20210331_pre.xml EX-101.PRE 319235
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 21929254
SIC: 2834 Pharmaceutical Preparations